Advocacy Opportunity / EGFR: see details within post

[NikoleV]

Fellow patient and writer Annabelle Gurwitch is writing about her experiences with insurance coverage for her gene mutation targeted medication. She'd love to speak with you and asked us to reach out on her behalf. She is especially interested in covering the topic of third-party copay maximizers. She is also interested in speaking to anyone who is on Medicaid and receiving a targeted therapy, and your experiences with insurance coverage.

Please email Nikki Martin, Senior Director, Precision Medicine Initiatives (nmartin@lungevity.org) who will connect you with Annabelle.